Electroencephalography (EEG) remains the definitive modality for detecting non-convulsive seizures, characterizing encephalopathy, and interrogating large-scale brain network dysfunction. Time to EEG matters However, conventional EEG workflows are poorly aligned with the temporal, operational, and workforce realities of modern acute and frontline care. As a result, EEG is frequently delayed or unavailable at the moment clinical decisions carry the greatest consequence. Point-of-care EEG (POC-EEG) has emerged to bridge this gap by enabling rapid, bedside neurophysiologic assessment, decentralizing EEG acquisition, and expanding access through automation and tele-neurophysiology. This review synthesizes contemporary evidence on POC-EEG with a primary focus on the NeuroTrace platform, integrating data from acute neurological emergencies, critical care, emergency medicine, and translational outpatient indications. We outline the unmet need driving adoption, examine diagnostic and health-system impact, and identify clinical indications with the greatest demonstrated and emerging benefit. We further situate NeuroTrace within the evolving landscape of high-fidelity, scalable EEG technologies and discuss future directions for biomarker development, guideline-concordant implementation, and outcome-driven validation.